Jump to: navigation, search
Illustration of HLA-DQ with peptide in the binding pocket
major histocompatibility complex, class II, DQ7
Haplotypes DQA1*0302:DQB1*0301 DQA1*0303:DQB1*0301 DQA1*0401:DQB1*0301 DQA1*0505:DQB1*0301 DQA1*0601:DQB1*0301
Structure (See HLA-DQ)
alpha 1 *0302 *0303 *0401 *0505 *0601
Symbol(s) HLA-DQA1
beta 1 *0301 *0304
Symbol(s) HLA-DQB1
Shared data
Locus chr.6 6p21.31

HLA-DQ7 (DQ7) is an HLA-DQ serotype that recognizes the common HLA DRB1*0301[1] and the less common HLA DRB1*0304 gene products. DQ7 is a form of 'split antigen' of the broad antigen group DQ3 which also contains DQ8 and DQ9.

DQ7 is linked by haplotype to a number of DQA1 (DQ alpha chain) genes, producing in cis-haplotype form, a large number of DQ αβ isoforms. These DQ alpha chains are also known to form transhaplotype isomers with other HLA-DQ.

DQ7 is linked to the following alpha chains genes (DQA1*)

  • 03 - *0301, *0302, *0303
  • 0401
  • 0505
  • 0601


Serotyping efficiency.

DQ3, DQ7, DQ8, and DQ9 recognition of Some DRB1*and [2]
DQB1* DQ7 DQ3 DQ8 Sample
allele % % % size (N)
0301 85 40 1 12220
0304 40 35 8 111


DQB1*0301 appears to be associated with lupus anticoagnulnat.[3]


DQ haplotypes of this serotype are formed between the cis-chromosomal genes of the DQA1 locus. This includes DQA1*0301, *0302, *0303, *0401, *0505, *0601.

There is a rather large degree of disequilibration about DQA1*0301 suggesting that this is one of the older and more established HLA DQB1* alleles in eurasia. The intron structure of DQB1 suggest that DQB1*0301 DQB1*0302/*0303 split occurred before DQB1*0302/*0303, the distribution of *03 in Africa suggest that recombination DQA1*03:DQB1*0301 are primarily the result of recombination events that have occurred in Africa. A recent study of Myastenia Gravis in Houston confirms the presence of A*0505:B*0301 in Nigeria. B1*0301 and A1*03 haplotypes are found at relatively high frequencies in SE Asia and Austronesia, also indicating that it is well established in the exoafrican population.


The DQ7.3 haplotpye can be formed by DQA1*0301:DQB1*0301, DQA1*0302:DQB1*0301, DQA1*0303:DQB1*0301. In the west the DQA1*0303:DQB1*0301 haplotype appears to be more common. The gene products of all 3 function similarly and a subunits are interchangeable. In the literature, older testing recognize DQA1*0303 as DQA1*0302, and still older tests recognize all three as DQA1*03 or DQA1*0301.

DQA1*0303:DQB1*0301 may be invovled in narcolepsy.[4] DQ7.3 appears to be associated with oral ulcerations and gingival disease [5]


DQA1*0401:DQB1*0301 (DQ7.4)


DQA1*0505:DQB1*0301 (DQ7.5) was gene-typed as DQA1*0501:DQB1*0301 until it was recognized that there was amino acid sequence variant in the preprocessed DQA1* gene product (proto-α-chain polypeptide encoded DQA1*0505). This protoalpha, once processed, is identical to the DQA1*0501 encoded α-chain. The DR5-DQ7.5 is very common in the South Eastern Europe and the Levant, with DQ7.5 reaching a haplotype frequency of 40% in Lebanon. Its high level is probably not by chance, the haplotype appears to protect against juvenile diabetes, which appears to be more common among cereal eating peoples. Cereals were first domesticated in the Near and Middle East more than 10,000 years ago and selection may explain its high levels. This makes analysis of the allele frequencies in Europeans complicated.

The processed alpha subunit of DQA1*0505 is identical to that of DQA1*0501, but some slight differences in the association with autoimmune disease are observed, possibly as a result of linked DR and DQB1 genes. DQA1*0505 can play into celiac disease under two circumstances. First it can increase risk when DQ2.5 is present, although current studies indicate that it marginally increases risk relative to DQB1*0202 in DQ2.5 cis haplotype. DQA1*0505, alone is found in a small percentage of celiacs (without DQ2 or DQ8).

DQ7.5 is found also high in frequency in the new world, but with DR types less commonly encountered in the old world. DQA1*05 allele is not clear in the new world. DQB1*0301 may be under current positive selection in the human population, at least in areas where DQ2.5 and DQ8 are high, as it confers resistance to type 1 diabetes. For hepatitis types B & C, HLA DQ7 may also be protective. DQA1*0505, DQB1*0301 appear to increase the risk for melanoma in the Spanish population however this may have a linkage to more recent fair skinned migrants. DQB1*0301 is also associated with allergic fungal sinisitus, human papillomavirus (HPV) induced warts, limited cutaneous systemic schlerosis in Africans, primary sclerosing cholangitis in Southern Europeans. DQB1*0301 does not to play a role in any frequently occurring autoimmune disease and its presence in the near east and suppressed frequencies of coeliac disease and Type 1 diabetes in these regions is suggestive that it has a positive selection in post-mesolithic cereal based societies in the Western Eurasia.

Narcolepsy - predisposing effects.[4]

DQB1*0301 appears to be more associated with early onset myasthenia gravis in Japanese than DQ8, and was also found along with DQB1*0304 to be associated with Chinese MG. DQ7 or asscoiated DR types may play a role in rheumatoid arthritis. In celiac disease the DQ7 (A*0505/1) can mediate celiac disease when HLA DQ2.2 is also present. HLA DQB1*0301 in Turks is associated with Thymoma but the risk may be associated with HLA class I loci.


DQA1*0601:DQB1*0301 (DQ7.6) is a globally rare haplotype, however it is found at high frequencies in the South Pacific and along the West Pacific rim. DQA1*0301 appears to be uniquely linked to DQA1*0601. DQ7.6 is positively associated with asthma,[6] early onset pauciarticular juvenile chronic arthritis without anti-nuclear antibodies,[7] DQ7.6 is negatively associated (Protective against) juvenile diabetes,[8] hepatosplenic disease in Schistosoma japonicum infection,[9] pulmonary tuberculosis.[10]


  1. Bunce M, Taylor CJ, Welsh KI (1993). "Rapid HLA-DQB typing by eight polymerase chain reaction amplifications with sequence-specific primers (PCR-SSP)". Hum. Immunol. 37 (4): 201–6. PMID 7905469.
  2. derived from IMGT/HLA
  3. Arnett FC, Olsen ML, Anderson KL, Reveille JD (1991). "Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant". J. Clin. Invest. 87 (5): 1490–5. PMID 1673688.
  4. 4.0 4.1 Hong SC, Lin L, Lo B; et al. (2007). "DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans". Hum. Immunol. 68 (1): 59–68. doi:10.1016/j.humimm.2006.10.006. PMID 17207713.
  5. pmid 8052655
  6. Guo X, Ni P, Li L (2001). "[Association between asthma and the polymorphism of HLA-DQ genes]". Zhonghua Jie He He Hu Xi Za Zhi (in Chinese). 24 (3): 139–41. PMID 11802952.
  7. Donn RP, Thomson W, Pepper L; et al. (1995). "Antinuclear antibodies in early onset pauciarticular juvenile chronic arthritis (JCA) are associated with HLA-DQB1*0603: a possible JCA-associated human leucocyte antigen haplotype". Br. J. Rheumatol. 34 (5): 461–5. PMID 7788177.
  8. Chuang LM, Jou TS, Wu HP; et al. (1995). "HLA DQA1 genotypes and its interaction with HLA DQB1 in Chinese IDDM living in Taiwan". Proc. Natl. Sci. Counc. Repub. China B. 19 (2): 73–9. PMID 7624445.
  9. Waine GJ, Ross AG, Williams GM, Sleigh AC, McManus DP (1998). "HLA class II antigens are associated with resistance or susceptibility to hepatosplenic disease in a Chinese population infected with Schistosoma japonicum". Int. J. Parasitol. 28 (4): 537–42. PMID 9602373.
  10. Vejbaesya S, Chierakul N, Luangtrakool K, Srinak D, Stephens HA (2002). "Associations of HLA class II alleles with pulmonary tuberculosis in Thais". Eur. J. Immunogenet. 29 (5): 431–4. PMID 12358854.